A carregar...

Ezetimibe: Its Novel Effects on the Prevention and the Treatment of Cholesterol Gallstones and Nonalcoholic Fatty Liver Disease

The cholesterol absorption inhibitor ezetimibe can significantly reduce plasma cholesterol concentrations by inhibiting the Niemann-Pick C1-like 1 protein (NPC1L1), an intestinal sterol influx transporter that can actively facilitate the uptake of cholesterol for intestinal absorption. Unexpectedly,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: de Bari, Ornella, Neuschwander-Tetri, Brent A., Liu, Min, Portincasa, Piero, Wang, David Q.-H.
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3216277/
https://ncbi.nlm.nih.gov/pubmed/22132342
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/302847
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!